Results 71 to 80 of about 23,220 (218)
MUCOLYTICS IN BRONCHOPULMONARY DYSPLASIA THERAPY
Mucolytic drugs, particularly, direct action mucolytics with acetylcysteine derivatives among them, are included in the complex therapy of the bronchopulmonary dysplasia exacerbations.
I. V. Davydova +3 more
doaj +1 more source
Lung interstitial cells during alveolarization [PDF]
Recent progress in neonatal medicine has enabled survival of many extremely low-birth-weight infants. Prenatal steroids, surfactants, and non-invasive ventilation have helped reduce the incidence of the classical form of bronchopulmonary dysplasia ...
Chang Won Choi
doaj +1 more source
An Introduction to Bronchopulmonary Dysplasia
Bronchopulmonary dysplasia (BPD) is both a significant clinical problem associated with neonatal intensive care and a sign of the success of that care. It can best be understood in the context of the historical continuum of improving survivability for prematurely born infants.
openaire +2 more sources
Parental Perceptions on Antenatal Information About Extremely Preterm Birth: A Qualitative Study
ABSTRACT Aim Antenatal information is essential for families facing the possibility of an extremely preterm (EPT) birth. Their information needs are not always clear and communication can be challenging during this stressful, uncertain time. We explored parental perceptions about antenatal information provided during perinatal counselling about EPT ...
Gonzalo Solís‐García +8 more
wiley +1 more source
BRONCHOPULMONARY DYSPLASIA IN INFANTS
The paper gives information on a frequent chronic lung disease, such as bronchopulmonary dysplasia, a life-threatening complication of neonatal respiratory distress syndrome, in developed countries.
Ovsyannikov D.Yu. +3 more
openaire +2 more sources
ABSTRACT Aim The aim was to investigate the incidence of sepsis and use of antibiotics among extremely preterm infants, given the limited number of population‐based studies examining this. Methods This retrospective study in Eastern Denmark included all liveborn infants from 23 + 0 weeks/days to 27 + 6 weeks/days of gestation from 2019 to 21.
Anna Bjerager Arnesen +10 more
wiley +1 more source
ABSTRACT Introduction Bronchopulmonary dysplasia (BPD) is a leading cause of morbidity and mortality in preterm infants. Combining surfactant with budesonide has been proposed to prevent BPD, but results from existing randomised controlled trials (RCTs) are conflicting.
James X. Sotiropoulos +12 more
wiley +1 more source
ABSTRACT Aim High‐flow nasal cannula (HFNC) and continuous positive airway pressure (CPAP) are options for respiratory support in infants with bronchiolitis. The aim of this study was to evaluate the use of HFNC and CPAP in infants with bronchiolitis at five hospitals in Norway to study time trends over seasons and differences in use between hospitals.
Knut Øymar +11 more
wiley +1 more source
ABSTRACT Aim To examine motor competence at 12 years, and its association to motor performance in infancy, in children born very preterm without cerebral palsy. Methods We prospectively assessed a regional cohort of 111 very preterm children, who were born in Sweden from 2004 to 2007 at 22–32 weeks of gestation.
Cecilia Montgomery +6 more
wiley +1 more source

